Adverse late health outcomes among children treated with <scp>3D</scp> radiotherapy techniques: Study design of the <scp>Dutch</scp> pediatric <scp>3D‐RT</scp> study
Josien G.M. Beijer(Princess Máxima Center), Cécile M. Ronckers(Johannes Gutenberg University Mainz), Helena J. H. van der Pal, Eline van Dulmen‐den Broeder(Erasmus MC), Jop C. Teepen(Princess Máxima Center), Judith L. Kok(Princess Máxima Center), Martha A. Grootenhuis(University of Amsterdam), Marloes Louwerens(Leiden University Medical Center), Jaap den Hartogh(University of Lucerne), Arjan Bel(Amsterdam UMC Location University of Amsterdam), Leontien C.M. Kremer(University Medical Center Utrecht), Wim J. E. Tissing(University Medical Center Groningen), Nina Streefkerk(Princess Máxima Center), P.S. Kroon(University Medical Center Utrecht), Margriet van der Heiden‐van der Loo(Princess Máxima Center), Geert O. Janssens(University Medical Center Utrecht), M. Wendling(Radboud University Nijmegen), Cleo Slagter(Erasmus MC), Jacqueline J. Loonen(Radboud University Nijmegen), Andrica C. H. de Vries(Princess Máxima Center), John H. Maduro(University Medical Center Groningen)
Cited by 2
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553